Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. It operates through the Pharmaceutical Products Business and Other Business segments. The Pharmaceutical Products Business segment handles prescription and generic drugs, diagnostics, and consumer healthcare business in Japan, which manages over-the-counter drugs. The Other Business segment deals with food additives and chemicals. The company was founded by Toyoji Naito in November 1936 and is headquartered in Tokyo, Japan.
Company profile
Ticker
ESALF, ESAIY
Exchange
Website
CEO
Haruo Naito
Employees
Location
Industry (SIC)
SEC CIK
ESALF stock data
Latest filings (excl ownership)
F-6EF
Automatic registration for ADRs (foreign)
6 Mar 23
F-6EF
Automatic registration for ADRs (foreign)
9 Feb 23
F-6
Registration for ADRs (foreign)
20 Jan 23
F-6EF
Automatic registration for ADRs (foreign)
9 Jan 23
F-6EF
Automatic registration for ADRs (foreign)
7 Jun 17
F-6EF
Automatic registration for ADRs (foreign)
25 May 04
424B1
Prospectus with pricing info
2 Apr 02
Latest ownership filings
No filings